Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

Document › Details

Voluntis S.A.. (11/23/20). "Press Release: Voluntis Successfully Completes a Capital Increase of €5.9 Million and Finalizes the Financing of Its Strategic Roadmap [Not for US, CA, AU or JP] Japan.". Cambridge, MA & Paris.

	Organisation	Voluntis S.A. (Euronext Paris: VTX)
	Group	Voluntis (Group)
	Organisation 2	Debiopharm Innovation Fund S.A.
	Group	Debiopharm (Group)
	Product	digital health
	Product 2	venture capital
	Index term	Voluntis–SEVERAL: investment, 202011 capital increase €5.93m net €5.7m led by Debiopharm Innovation Fund
	Person	Leurent, Pierre (Voluntis 201805 CEO + Co-Founder)
	Person 2	Dowe, Tanja (Debiopharm 201705 Head of Debiopharm Innovation Fund)

Original document
accessed by [iito] on 2020-11-24

Record changed: 2020-11-30

Picture [iito] Plain Stupid Simple 650x80px

More documents for Voluntis (Group)

[1] Voluntis S.A.. (3/4/20). "Press Release: Voluntis Announces Its New Strategic Roadmap. Strategic Prioritization of the Oncology Business". Cambridge, MA & Paris....
[2] Voluntis S.A.. (3/3/20). "Press Release: Voluntis and Bristol-Myers Squibb to Co-develop Digital Therapeutics for Oncology". New York, NY & Paris....
[3] Voluntis S.A.. (12/18/19). "Press Release: Voluntis Announces New Pharma Collaboration in Oncology". Cambridge, MA & Paris....
[4] Voluntis S.A.. (12/16/19). "Press Release: Voluntis Collaborates with Salesforce to Introduce Full-Service Platform for Digital Therapeutics Prescription and Reimbursement". Cambridge, MA & San Francisco, CA....
[5] Euronext N.V.. (5/30/18). "Press Release: Digital Biotech Voluntis Lists on Euronext". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]